94 related articles for article (PubMed ID: 12532816)
1. [Parkinson's disease and oxidative stress].
Zhou Y; Xie JX
Sheng Li Ke Xue Jin Zhan; 1999 Apr; 30(2):169-72. PubMed ID: 12532816
[No Abstract] [Full Text] [Related]
2. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
Singh C; Ahmad I; Kumar A
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):19-28. PubMed ID: 17543230
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and neuroprotection in Parkinson's disease: implications from studies on dopamine-induced apoptosis.
Offen D; Hochman A; Gorodin S; Ziv I; Shirvan A; Barzilai A; Melamed E
Adv Neurol; 1999; 80():265-9. PubMed ID: 10410731
[No Abstract] [Full Text] [Related]
4. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
5. Can we prevent Parkinson's and Alzheimer's disease?
Kedar NP
J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
[TBL] [Abstract][Full Text] [Related]
6. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
7. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
Hajieva P; Mocko JB; Moosmann B; Behl C
J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
Mariani E; Polidori MC; Cherubini A; Mecocci P
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood markers of oxidative stress in Parkinson's disease.
Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald A; Lotharius J
Exp Neurol; 2005 Jun; 193(2):279-90. PubMed ID: 15869932
[TBL] [Abstract][Full Text] [Related]
12. Research in motion: the enigma of Parkinson's disease pathology spread.
Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease: oxidative stress and therapeutic approaches.
Surendran S; Rajasankar S
Neurol Sci; 2010 Oct; 31(5):531-40. PubMed ID: 20221655
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population.
Sharma A; Kaur P; Kumar B; Prabhakar S; Gill KD
Parkinsonism Relat Disord; 2008; 14(1):52-7. PubMed ID: 18032086
[TBL] [Abstract][Full Text] [Related]
15. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
[TBL] [Abstract][Full Text] [Related]
16. Uric acid in Parkinson's disease.
Schlesinger I; Schlesinger N
Mov Disord; 2008 Sep; 23(12):1653-7. PubMed ID: 18618666
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of Parkinson's disease.
Gandhi S; Wood NW
Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
[TBL] [Abstract][Full Text] [Related]
18. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.
Ahlskog JE
Mov Disord; 2005 Mar; 20(3):271-82. PubMed ID: 15580550
[TBL] [Abstract][Full Text] [Related]
19. Free radical toxicity and antioxidants in Parkinson's disease.
Sudha K; Rao AV; Rao S; Rao A
Neurol India; 2003 Mar; 51(1):60-2. PubMed ID: 12865518
[TBL] [Abstract][Full Text] [Related]
20. Dopamine and Parkinson's disease: is the killer in the house?
Chesselet MF
Mol Psychiatry; 2003 Apr; 8(4):369-70. PubMed ID: 12740592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
